Subject characteristics | HIV-positive | HIV-negative | p-value |
N | 52 | 55 | – |
Male | 44 (85%) | 40 (73%) | 0.14 |
Age (years) | 50.8 ± 7.1 | 54.0 ± 7.5 | 0.03 |
Education (years) | 14.4 ± 2.3 | 15.2 ± 2.4 | 0.06 |
Race |
|
|
|
Caucasian | 28 (54%) | 36 (65%) | 0.31 |
African American/Black | 0 (0%) | 1 (2%) | |
Native Hawaiian/Pacific Islander | 7 (14%) | 0 (0%) | |
Asian | 6 (11%) | 6 (11%) | |
More than one race | 10 (19%) | 12 (22%) | |
Unknown | 1 (2%) | 0 (0%) |
|
Hispanic ethnicity | 9 (17%) | 5 (9%) | 0.26 |
Years since HIV diagnosis | 13.3 ± 6.7 | – | – |
Years on combination antiretroviral therapy | 11.2 ± 6.0 | – | – |
Nadir CD4 count (cells/mm3), median (Q1 - Q3) | 116.0 (34.0 - 251.5) | – | – |
Current CD4 count (cells/mm3) median (Q1 - Q3) | 460.5 (291.5 - 594.3) | – | – |
Undetectable plasma HIV RNA (<50 copies/mL) | 43 (83%) | – | – |
Diabetes | 4 (8%) | 1 (2%) | 0.15 |
Hypertension | 13 (25%) | 11 (20%) | 0.54 |
History of myocardial infarction | 1 (2%) | 0 (0%) | 0.49 |
Cannabis use | |||
Ever used | 48 (92%) | 44 (80%) | 0.07 |
Recent use | 25 (52%A) | 9 (21%A) | 0.002 |
Lifetime frequency of use (0 - 10 times) | 13 (25%) | 23 (42%) | 0.07 |
Lifetime frequency of use (>10 times) | 39 (75%) | 32 (58%) | |
Duration of cannabis use (years) | 10.0 (5.0 - 30.0) | 6.0 (1.0 - 20.0) | 0.02‡ |
Tobacco smoking | |||
Current smokers | 17 (33%) | 9 (16%) | 0.05 |
Ever smokers | 34 (65%) | 34 (62%) | 0.70 |
Alcohol Use° |
|
| |
Never | 20 (39%) | 14 (26%) | 0.09 |
Occasional | 20 (39%) | 20 (36%) | |
Frequent | 10 (20%) | 21 (38%) |